EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Substance use in a Dutch migraine cohort compared with the general population

Thomas C van den Hoek, Iris E Verhagen iD, Irene de Boer, Gisela M Terwindt

Headache: The Journal of Head and Face Pain · 2024

DOI: 10.1111/head.14663 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, 2024. Written by Thomas C van den Hoek and 3 co-authors. Institution: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Major MEDLINE topics: Migraine Disorders, Substance-Related Disorders. Cited 4 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To evaluate self‐reported substance user profiles for individuals with migraine and compare these to the general population.

Background

There is increasing attention to lifestyle influences such as substance use as presumed migraine triggers.

Methods

Data on substance use were collected by survey in a large migraine cohort and from the biannual survey in the general Dutch population for substances. A representative cohort of Dutch patients with migraine ( n = 5176) and the Dutch general population ( n = 8370) was included. Patients with migraine were subdivided into episodic (EM) and chronic migraine (CM). Substance consumption was compared between the general population and patients with migraine, and between migraine subgroups after standardization for sex and level of education.

Results

Included patients with migraine were 83.4% female (4319/5176) and had a mean (standard deviation) age of 44.8 (11.3) years. Patients with migraine reported less illicit drug use (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.42–0.55; p < 0.001), less current and lifetime smoking (OR 0.60, 95% CI 0.55–0.65; p < 0.001 and OR 0.75, 95% CI 0.71–0.79; p < 0.001), and less current alcohol consumption (OR 0.66, 95% CI 0.62–0.70; p < 0.001) compared with the general population. Prevalence of substance use was compared between CM and EM participants and showed higher illicit drug use (OR 1.73, 95% CI 1.11–2.69; p = 0.011), higher current smoking (OR 1.61, 95% CI 1.22–2.11; p < 0.001) but less alcohol use (OR 0.54, 95% CI 0.43–0.68; p < 0.001) for participants with CM compared with EM. No differences were found for a history of smoking (OR 1.18, 95% CI 0.92–1.50, p = 0.19).

Conclusions

Individuals with migraine are less likely to use illicit drugs, smoke, or drink alcohol compared with the general population. Patients with CM less often consume alcohol, while they more often use illicit drugs and smoke compared to those with EM.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersSubstance-Related DisordersAdultFemaleHumansMaleIllicit DrugsSurveys and QuestionnairesMiddle AgedSmokingNetherlands

Author keywords

chronic migraineepidemiologic researchepisodic migrainelifestyletriggers

Substances

Illicit Drugs

Authors and institutions

  • Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.

ORCID profiles: Iris E Verhagen

Cite

APA

van den Hoek, T. C., Verhagen, I. E., de Boer, I., & Terwindt, G. M. (2024). Substance use in a Dutch migraine cohort compared with the general population. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14663

Vancouver

van den Hoek TC, Verhagen IE, de Boer I, Terwindt GM. Substance use in a Dutch migraine cohort compared with the general population. Headache: The Journal of Head and Face Pain. 2024. doi:10.1111/head.14663

BibTeX
@article{vandenHoek2024,
  author = {van den Hoek, Thomas C and Verhagen, Iris E and de Boer, Irene and Terwindt, Gisela M},
  title = {Substance use in a Dutch migraine cohort compared with the general population},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  doi = {10.1111/head.14663}
}
Start for free →